DIOSynVax

Hertford, United Kingdom · Founded 2017 · Privately Held (backing)

Operator of a vaccine antigen design company intended to accelerate vaccine development to maximize the protection against existing and future viruses. DIOSynVax is based in Hertford, United Kingdom and was founded in 2017. Its last reported valuation was $31.6 million in Dec 2025. It has raised $9.8 million.

Last reported valuation

$31.6M

Oct 2026

Priced at

—

Total raised

$9.8M

Last round

—

How much has DIOSynVax raised?

$9.8Macross 0 recorded rounds

Private Market View

More of DIOSynVax with a free Private Market View account

·Watch DIOSynVax: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

DIOSynVax investors

7 investors are on record for DIOSynVax, including Innovate UK, Gates Foundation, Parkwalk Advisors and Coalition for Epidemic Preparedness Innovations.

For fundraisers

Raising for a company like DIOSynVax?

7 investors have backed DIOSynVax.

See all 7 investors →

Frequently asked about DIOSynVax

How much has DIOSynVax raised?: DIOSynVax has raised $9.8M in total across 0 recorded funding rounds.